Tamifluhttp://www.unboundmedicine.com/medline/ebm/research/TamifluUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.A randomized, open-label, 2-period, crossover bioequivalence study of two oral formulations of 75 mg oseltamivir in healthy Thai volunteers.http://www.unboundmedicine.com/medline/ebm/record/19049700/full_citation/A_randomized_open_label_2_period_crossover_bioequivalence_study_of_two_oral_formulations_of_75_mg_oseltamivir_in_healthy_Thai_volunteers_Kongpatanakul S, Chatsiricharoenkul S, Panich U, et al. 
A randomized, open-label, 2-period, crossover bioequivalence study of two oral formulations of 75 mg oseltamivir in healthy Thai volunteers. [JOURNAL ARTICLE]
Int J Clin Pharmacol Ther 2008 Dec; Volume 46(December):654-662.
Abstract | Full Citation | Find Related Articles Anti-influenza drugs: the development of sialidase inhibitors.http://www.unboundmedicine.com/medline/ebm/record/19048199/full_citation/Anti_influenza_drugs:_the_development_of_sialidase_inhibitors_Itzstein M, Thomson R 
Anti-influenza drugs: the development of sialidase inhibitors. [Journal Article]
Handb Exp Pharmacol 2009; (189):111-54.
Abstract | Full Citation | Find Related Articles A Novel Neuraminidase Deletion Mutation Conferring Resistance to Oseltamivir in Clinical Influenza A/H3N2 Virus.http://www.unboundmedicine.com/medline/ebm/record/19046066/full_citation/A_Novel_Neuraminidase_Deletion_Mutation_Conferring_Resistance_to_Oseltamivir_in_Clinical_Influenza_A/H3N2_Virus_Abed Y, Baz M, Boivin G 
A Novel Neuraminidase Deletion Mutation Conferring Resistance to Oseltamivir in Clinical Influenza A/H3N2 Virus. [JOURNAL ARTICLE]
J Infect Dis 2008 Dec 1.
Abstract | Full Citation | Publisher Full Text | Find Related Articles [Prevention and treatment of influenza]http://www.unboundmedicine.com/medline/ebm/record/19044051/full_citation/[Prevention_and_treatment_of_influenza]Chidiac C 
[Prevention and treatment of influenza] [English Abstract, Journal Article]
Rev Prat 2008 Oct 15; 58(15):1671-7.
Abstract | Full Citation | Find Related Articles A Patient with Fulminant Influenza-Related Bacterial Pneumonia Due to Streptococcus pneumoniae Followed by Mycobacterium tuberculosis Infection.http://www.unboundmedicine.com/medline/ebm/record/19043258/full_citation/A_Patient_with_Fulminant_Influenza_Related_Bacterial_Pneumonia_Due_to_Streptococcus_pneumoniae_Followed_by_Mycobacterium_tuberculosis_Infection_Seki M, Suyama N, Hashiguchi K, et al. 
A Patient with Fulminant Influenza-Related Bacterial Pneumonia Due to Streptococcus pneumoniae Followed by Mycobacterium tuberculosis Infection. [Journal Article]
Intern Med 2008; 47(23):2043-7.
Abstract | Full CitationAnalysis of oseltamivir in tamiflu((r)) capsules using micellar electrokinetic chromatography.http://www.unboundmedicine.com/medline/ebm/record/19043232/full_citation/Analysis_of_oseltamivir_in_tamiflu__r___capsules_using_micellar_electrokinetic_chromatography_Jabbaribar F, Mortazavi A, Jalali-Milani R, et al. 
Analysis of oseltamivir in tamiflu((r)) capsules using micellar electrokinetic chromatography. [Journal Article]
Chem Pharm Bull (Tokyo) 2008 Dec; 56(12):1639-44.
Abstract | Full Citation | Find Related Articles Avian influenza A/H5N1 neuraminidase expressed in yeast with a functional head domain.http://www.unboundmedicine.com/medline/ebm/record/19038288/full_citation/Avian_influenza_A/H5N1_neuraminidase_expressed_in_yeast_with_a_functional_head_domain_Yongkiettrakul S, Boonyapakron K, Jongkaewwattana A, et al. 
Avian influenza A/H5N1 neuraminidase expressed in yeast with a functional head domain. [JOURNAL ARTICLE]
J Virol Methods 2008 Nov 24.
Abstract | Full Citation | Find Related Articles [The impact of antibiotic treatment in patients with influenza-like illness]http://www.unboundmedicine.com/medline/ebm/record/19035224/full_citation/[The_impact_of_antibiotic_treatment_in_patients_with_influenza_like_illness]Cao B, Li R, Liu YM, et al. 
[The impact of antibiotic treatment in patients with influenza-like illness] [English Abstract, Journal Article]
Zhonghua Jie He He Hu Xi Za Zhi 2008 Jul; 31(7):483-7.
Abstract | Full CitationLimited brain distribution of Ro 64-0802, a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4).http://www.unboundmedicine.com/medline/ebm/record/19029202/full_citation/Limited_brain_distribution_of_Ro_64_0802_a_pharmacologically_active_form_of_oseltamivir_by_active_efflux_across_the_blood_brain_barrier_mediated_by_organic_anion_transporter_3__Oat3/Slc22a8__and_multidrug_resistance_associated_protein_4__Mrp4/Abcc4__Ose A, Ito M, Kusuhara H, et al. 
Limited brain distribution of Ro 64-0802, a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4). [JOURNAL ARTICLE]
Drug Metab Dispos 2008 Nov 24.
Abstract | Full Citation | Find Related Articles Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.http://www.unboundmedicine.com/medline/ebm/record/19026027/full_citation/Assessment_of_neuropsychiatric_adverse_events_in_influenza_patients_treated_with_oseltamivir:_a_comprehensive_review_Toovey S, Rayner C, Prinssen E, et al. 
Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review. [Journal Article]
Drug Saf 2008; 31(12):1097-114.
Abstract | Full Citation | Find Related Articles